Trogocytosis represents a novel mechanism of action of daratumumab in multiple myeloma
Trogocytosis represents a novel mechanism of action of daratumumab in multiple myeloma |
https://doi.org/10.18632/oncotarget.26098
Jakub Krejcik,
and Niels W.C.J. van de Donk
|
33621-33622 |
Procarbazine, CCNU and vincristine (PCV) versus temozolomide chemotherapy for patients with low-grade glioma: a systematic review
Procarbazine, CCNU and vincristine (PCV) versus temozolomide chemotherapy for patients with low-grade glioma: a systematic review |
https://doi.org/10.18632/oncotarget.25890
Karim Hafazalla,
Arjun Sahgal,
Blessing Jaja,
James R. Perry,
and Sunit Das
|
33623-33633 |
Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma
Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma |
https://doi.org/10.18632/oncotarget.25950
Amy M. Buckley,
Niamh Lynam-Lennon,
Susan A. Kennedy,
Margaret R. Dunne,
John J. Aird,
Emma K. Foley,
Niamh Clarke,
Narayanasamy Ravi,
Dermot O’Toole,
John V. Reynolds,
Breandán N. Kennedy,
and Jacintha O’Sullivan
|
33634-33647 |
Rapid detection of copy number variations and point mutations in BRCA1/2 genes using a single workflow by ion semiconductor sequencing pipeline
Rapid detection of copy number variations and point mutations in BRCA1/2 genes using a single workflow by ion semiconductor sequencing pipeline |
https://doi.org/10.18632/oncotarget.26000
Aldo Germani,
Fabio Libi,
Stefano Maggi,
Gianluca Stanzani,
Augusto Lombardi,
Patrizia Pellegrini,
Mauro Mattei,
Laura De Marchis,
Claudio Amanti,
Antonio Pizzuti,
Maria Rosaria Torrisi,
and Maria Piane
|
33648-33655 |
Modulation of genomic and epigenetic end-points by celecoxib
Modulation of genomic and epigenetic end-points by celecoxib |
https://doi.org/10.18632/oncotarget.26062
Alberto Izzotti,
Sebastiano La Maestra,
Rosanna T. Micale,
Alessandra Pulliero,
Marta Geretto,
Roumen Balansky,
and Silvio De Flora
|
33656-33681 |
Oxygenation/non-invasive ventilation strategy and risk for intubation in immunocompromised patients with hypoxemic acute respiratory failure
Oxygenation/non-invasive ventilation strategy and risk for intubation in immunocompromised patients with hypoxemic acute respiratory failure |
https://doi.org/10.18632/oncotarget.26069
Guillaume Dumas,
Sylvie Chevret,
Virginie Lemiale,
Frédéric Pène,
Alexandre Demoule,
Julien Mayaux,
Achille Kouatchet,
Martine Nyunga,
Pierre Perez,
Laurent Argaud,
François Barbier,
François Vincent,
Fabrice Bruneel,
Kada Klouche,
Loay Kontar,
Anne-Sophie Moreau,
Jean Reignier,
Laurent Papazian,
Yves Cohen,
Djamel Mokart,
and Elie Azoulay
|
33682-33693 |
Ex vivo generation of umbilical cord blood T regulatory cells expressing the homing markers CD62L and cutaneous lymphocyte antigen
Ex vivo generation of umbilical cord blood T regulatory cells expressing the homing markers CD62L and cutaneous lymphocyte antigen |
https://doi.org/10.18632/oncotarget.26097
Joshua N. Kellner,
Eric Yvon,
and Simrit Parmar
|
33694-33701 |
Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study
Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study |
https://doi.org/10.18632/oncotarget.26101
Francesca De Felice,
Giancarlo D’Ambrosio,
Daniela Musio,
Franco Iafrate,
Ilaria Benevento,
Marco Marzo,
Marialaura Mancini,
Federica Urbano,
Marcella Iannitti,
Francesco Marampon,
Nadia Bulzonetti,
Enrico Cortesi,
and Vincenzo Tombolini
|
33702-33709 |
STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells
STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells |
https://doi.org/10.18632/oncotarget.26110
Uri Rozovski,
David M. Harris,
Ping Li,
Zhiming Liu,
Preetesh Jain,
Alessandra Ferrajoli,
Jan Burger,
Phillip Thompson,
Nitin Jain,
William Wierda,
Michael J. Keating,
and Zeev Estrov
|
33710-33718 |
Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment
Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment |
https://doi.org/10.18632/oncotarget.26120
Concetta Elisa Onesti,
Claire Josse,
Aurélie Poncin,
Pierre Frères,
Christophe Poulet,
Vincent Bours,
and Guy Jerusalem
|
33719-33733 |
Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review
Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review |
https://doi.org/10.18632/oncotarget.25989
Xiaofeng Li,
Yueming He,
Jinfeng Zhu,
Hongxia Pang,
Yongwei Lin,
and Jinyang Zheng
|
33734-33738 |